Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)
Clinical trial NCT05453682 · RECRUITING
Trial details
- NCT number
- NCT05453682
- Sponsor
- Samsung Medical Center
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-14
- Primary completion
- 2026-12-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.